Published on 2/26/2021 in the Prospect News Structured Products Daily.
New Issue: Barclays sells $1.28 million phoenix autocallable notes on two funds
By Wendy Van Sickle
Columbus, Ohio, Feb. 26 – Barclays Bank plc priced $1.28 million of phoenix autocallable notes due Feb. 15, 2024 linked to the least performing of the Financial Select Sector SPDR fund and the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 13.8% if each fund closes at or above its 70% coupon barrier on a related observation date.
The notes will be called at par plus the contingent coupon if each fund closes at or above its initial level on any quarterly call observation date after six months.
The payout at maturity will be par plus any coupon unless any fund finishes below 70% of its initial value, in which case investors will lose 1% for each 1% decline of the worst performing fund.
Barclays is the agent.
| Issuer: | Barclays Bank plc
|
| Issue: | Phoenix autocallable notes
|
| Underlying funds: | Financial Select Sector SPDR fund, SPDR S&P Biotech ETF
|
| Amount: | $1,275,000
|
| Maturity: | Feb. 15, 2024
|
| Coupon: | 13.8% annualized, payable quarterly if each fund closes at or above coupon barrier on related observation date
|
| Price: | Par
|
| Payout at maturity: | Par plus any coupon unless any fund finishes below final barrier, in which case 1% loss for each 1% decline of the worst performing fund
|
| Call: | Automatically at par plus contingent coupon if each fund closes at or above initial level on any quarterly call observation date after six months
|
| Initial levels: | $164.32 for Biotech, $31.52 for Financial
|
| Coupon barrier levels: | $115.02 for Biotech, $22.06 for Financial; 70% of initial levels
|
| Final barrier levels: | $115.02 for Biotech, $22.06 for Financial; 70% of initial levels
|
| Pricing date: | Feb. 12
|
| Settlement date: | Feb. 18
|
| Agent: | Barclays
|
| Fees: | 0.35%
|
| Cusip: | 06748E5Y5
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
